Your browser doesn't support javascript.
loading
Quantification of transmission risk in a male patient with a FLNB mosaic mutation causing Larsen syndrome: Implications for genetic counseling in postzygotic mosaicism cases.
Bernkopf, Marie; Hunt, David; Koelling, Nils; Morgan, Tim; Collins, Amanda L; Fairhurst, Joanna; Robertson, Stephen P; Douglas, Andrew G L; Goriely, Anne.
Affiliation
  • Bernkopf M; Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
  • Hunt D; Nuffield Department of Clinical Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Koelling N; Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Morgan T; Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
  • Collins AL; Nuffield Department of Clinical Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Fairhurst J; Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
  • Robertson SP; Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Douglas AGL; Paediatric Radiology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Goriely A; Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Hum Mutat ; 38(10): 1360-1364, 2017 10.
Article in En | MEDLINE | ID: mdl-28639312
ABSTRACT
We report the case of a male patient with Larsen syndrome found to be mosaic for a novel point mutation in FLNB in whom it was possible to provide evidence-based personalized counseling on transmission risk to future offspring. Using dideoxy sequencing, a low-level FLNB c.698A>G, encoding p.(Tyr233Cys) mutation was detected in buccal mucosa and fibroblast DNA. Mutation quantification was performed by deep next-generation sequencing (NGS) of DNA extracted from three somatic tissues (blood, fibroblasts, saliva) and a sperm sample. The mutation was detectable in all tissues tested, at levels ranging from 7% to 10% (mutation present in ∼20% of diploid somatic cells and 7% of haploid sperm), demonstrating the involvement of both somatic and gonadal lineages in this patient. This report illustrates the clinical utility of performing targeted NGS analysis on sperm from males with a mosaic condition in order to provide personalized transmission risk and offer evidence-based counseling on reproductive safety.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteochondrodysplasias / Filamins / Genetic Counseling Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male Language: En Journal: Hum Mutat Journal subject: GENETICA MEDICA Year: 2017 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteochondrodysplasias / Filamins / Genetic Counseling Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male Language: En Journal: Hum Mutat Journal subject: GENETICA MEDICA Year: 2017 Type: Article Affiliation country: United kingdom